Stem Cell Gene Therapy for Sickle Cell Disease

Clinical trial NCT02247843 · COMPLETED

Trial details

NCT number: NCT02247843
Sponsor: Donald B. Kohn, M.D.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2014-12-01
Primary completion: 2025-09-24
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.